Company news
Futura Medical Plc (LSE:FUM) news
Futura Medical Plc news releases on 6ix. Latest, Sep 17, 2007: MED2002 Licensing Deal
Press releases — page 7
MED2002 Licensing Deal
September 17, 2007
Appt of Pain Relief Adviser
August 23, 2007
Positive Study Results
August 9, 2007
Holdings in Company
August 2, 2007
Grant Approval
July 27, 2007
Annual Report & Accounts
June 20, 2007
Final Results
May 30, 2007
MED2002 Update
May 14, 2007
CSD500 Patents granted
May 9, 2007
DermaSys Agreement with GSK
April 18, 2007
Launch of DermaSys Brand
February 28, 2007
Additional Listing
January 31, 2007
CSD500 Regulatory Update
November 16, 2006
Technical Seminar
October 12, 2006
DCF100 Skin Study Results
September 6, 2006
FLD500 Scale-up Trials
July 17, 2006
Share Dealing
July 7, 2006
New Product Update
July 6, 2006
Agreement with GSK
July 4, 2006
Comment on Press Speculation
June 21, 2006
Update on MED2002
May 9, 2006
Exclusivity Period Extension
February 10, 2006
Re: Global Rights
December 9, 2005
EU Marketing Submission
November 28, 2005
Study Results
November 21, 2005
Product development update
August 12, 2005
SSL acquires rights to FLD500
July 6, 2005
Manufacturing trials
April 25, 2005
Grant of options
March 22, 2005
Change of Advisers
February 28, 2005
Research Update
November 15, 2004
Notice of Results-Correction
September 21, 2004
Holding in Company
August 24, 2004
Reformulation of treatment
July 12, 2004
Sale of royalty rights
July 1, 2004
Results of clinical trial
May 26, 2004
Non-exercise of option
April 21, 2004
Final Results-Replacement
February 23, 2004
Exercising second call option
February 5, 2004
Re Agreement
January 19, 2004
DTI Grant Awarded
December 5, 2003
Announcement of Fundraising
November 28, 2003
Admission to AIM
July 22, 2003